• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Diabetic Dog Develops Recurrent Peritonitis Linked to Rare Bacterial Pseudomycetoma

by
November 9, 2026
in Biology, Health
Reading Time: 6 mins read
0
Diabetic Dog Develops Recurrent Peritonitis Linked to Rare Bacterial Pseudomycetoma

Diabetic Dog Develops Recurrent Peritonitis Linked to Rare Bacterial Pseudomycetoma

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A newly published clinical report details an uncommon presentation of chronic recurrent septic peritonitis in a diabetic dog, driven by persistent Staphylococcus pseudintermedius infection exhibiting the Splendore–Hoeppli phenomenon and bacterial pseudomycetoma formation. Septic peritonitis represents one of the most perilous surgical emergencies encountered in small animal veterinary medicine, carrying reported mortality rates ranging between 20 percent and 85 percent depending on underlying causes, intervention timing, and concurrent systemic conditions. While most cases arise from distinct gastrointestinal perforations, mesenteric tears, or biliary disruptions and resolve following surgical source control, a challenging subset transitions into a refractory, relapsing state. In this patient, a six-year-old neutered male Miniature Pinscher, the inflammatory process lacked an identifiable visceral perforation or discrete abscess, persisting across four successive clinical episodes over fourteen weeks. The clinical team observed that the bacterial colonies provoked an intense pyogranulomatous host response encased within dense immune deposits, demonstrating how opportunistic commensal organisms can exploit host immunopathy to establish protected intra-abdominal reservoirs.

The refractory nature of chronic intra-abdominal sepsis frequently stems from bacterial biofilms and localized immune complex deposition. In chronic septic peritonitis, microorganisms often produce an extracellular polymeric substance composed of polysaccharides, structural proteins, and extracellular DNA, establishing a sessile biofilm community. Within this sheltered matrix, bacteria adopt altered metabolic phenotypes and experience up to a thousand-fold increase in antimicrobial tolerance compared with planktonic organisms. Concurrently, the Splendore–Hoeppli phenomenon can develop around chronic antigenic foci, presenting histologically as radiating, eosinophilic, club-shaped or stellate structures. Composed of antigen-antibody complexes, fibrin, immunoglobulins, cellular debris, and degenerated inflammatory cells, this reaction represents an immune-mediated attempt to sequester infectious agents. Paradoxically, this dense proteinaceous barrier impedes neutrophil phagocytosis and restricts the tissue penetration of bactericidal antimicrobials. Although historically associated with fungal organisms and filamentous bacteria like Actinomyces and Nocardia, the reaction can accompany non-filamentous pathogens like Staphylococcus pseudintermedius, producing chronic suppurative lesions categorized as botryomycosis or bacterial pseudomycetoma.

Underlying host vulnerabilities contributed substantially to the persistent pathophysiology observed in this case. The patient had been diagnosed with diabetes mellitus two years prior to presentation, receiving management with porcine insulin zinc suspension. Historic glycemic control remained suboptimal, marked by pronounced swings between severe hyperglycemia and episodic hypoglycemia during intercurrent illnesses. Four months before referral, the dog underwent bilateral phacoemulsification for diabetes-associated cataracts and recovered uneventfully. However, one month following ocular surgery, the dog developed a right hip abscess that ruptured spontaneously. Aerobic culture of that lesion isolated both Staphylococcus aureus and Staphylococcus pseudintermedius, which resolved following surgical debridement, primary closure, and oral amoxicillin–clavulanate therapy. Chronic hyperglycemia impairs neutrophil chemotaxis, phagocytosis, and oxidative burst activity, while promoting microvascular dysfunction and blunting cellular immunity. In parallel, systemic sepsis induces peripheral insulin resistance, establishing a destabilizing cycle. Clinicians hypothesized that the earlier cutaneous infection may have served as a sentinel event or hematogenous reservoir seeding the peritoneal cavity.

The initial episode of septic peritonitis manifested in August 2025 with acute vomiting, abdominal distension, lethargy, and inappetence. Abdominocentesis yielded serosanguinous exudate containing marked neutrophilic inflammation and frequent intracellular cocci, prompting an urgent exploratory laparotomy. Surgical exploration revealed diffuse fibrinous peritonitis, substantial serosanguinous fluid, and pink proliferative tissue interspersed with white plaque-like deposits across the omentum and mesentery, without evidence of gastrointestinal perforation, biliary leakage, or visceral abscessation. The peritoneal space was lavaged extensively with warmed sterile saline, and a closed-suction Jackson–Pratt drain was positioned. Postoperatively, recovery was complicated by severe haemoabdomen, with the patient’s hematocrit falling to 17 percent and 300 milliliters of hemorrhagic effluent recovered from the peritoneal drain. Stabilization required a transfusion of packed red blood cells at 10 milliliters per kilogram alongside intravenous tranexamic acid administered every six hours. The abdominal drain was successfully removed at forty-eight hours when output dropped below two milliliters per kilogram daily, permitting discharge on oral amoxicillin–clavulanate.

Definitive laboratory and histological investigations characterized the precise microbiological identity and excluded competing differential etiologies. Aerobic culture of peritoneal fluid isolated Staphylococcus pseudintermedius in pure growth, demonstrating susceptibility to enrofloxacin, amoxicillin–clavulanate, cefovecin, chloramphenicol, meropenem, and rifampin, alongside resistance to penicillin and amoxicillin alone. Histopathological examination of omental biopsies confirmed severe pyogranulomatous peritonitis featuring bacterial microcolonies enclosed by radiating, eosinophilic Splendore–Hoeppli material. Because these findings closely mimicked fungal or filamentous bacterial infections, special histochemical stains were performed. Ziehl–Neelsen, modified acid-fast, periodic acid–Schiff, and Grocott methenamine silver stains were uniformly negative for Actinomyces, Nocardia, and fungal organisms. Additionally, enzyme immunoassays for Aspergillus galactomannan and Blastomyces antigen returned negative results, and mycobacterial cultures yielded no growth. Histopathology showed no atypical mitotic activity or mesothelial proliferation, effectively ruling out peritoneal carcinomatosis and mesothelioma. The repeated isolation of a single bacterial species in pure culture established the definitive diagnosis of intra-abdominal bacterial pseudomycetoma.

Approximately four weeks after initial discharge, the patient suffered a second clinical relapse characterized by renewed abdominal distension, anorexia, and fluid re-accumulation. Repeat point-of-care ultrasonography and abdominocentesis demonstrated degenerate neutrophils harboring intracellular cocci, necessitating a second exploratory laparotomy six weeks after the primary diagnosis. Intraoperative observations closely mirrored the initial surgery, displaying extensive fibrinous adhesions, thickened omental tissue, and discrete white nodular plaques scattered across the mesentery without mechanical bowel compromise. Surgeons performed extensive debridement of grossly abnormal omental tissue accompanied by copious warm saline peritoneal lavage and placed another closed-suction Jackson–Pratt drain. Repeat culture of biopsy specimens once again yielded Staphylococcus pseudintermedius with an antimicrobial susceptibility profile identical to the primary isolate. Postoperative therapy consisted of intravenous ampicillin–sulbactam at 30 milligrams per kilogram every eight hours and enrofloxacin at 10 milligrams per kilogram daily. Fluid cytology at forty-eight hours revealed no visible bacteria, prompting drain removal and discharge on oral enrofloxacin and prolonged suppressive amoxicillin–clavulanate therapy.

Four weeks later, approximately ten weeks from initial presentation, the dog developed a third clinical relapse manifesting as lethargy, diarrhea, elevated body temperature, and ventral cervical and forelimb edema. Laboratory panels documented marked thrombocytopenia, mild anemia, severe hyperglycemia, and an elevated C-reactive protein concentration reaching 83.7 milligrams per liter. Coagulation testing revealed hyperfibrinogenemia, a mildly prolonged activated partial thromboplastin time, and normal D-dimer concentrations, signaling evolving sepsis-associated coagulopathy and early disseminated intravascular coagulation. Peritoneal fluid cytology confirmed persistent degenerate neutrophils with intracellular cocci, and culture reiterated the identical Staphylococcus pseudintermedius strain. Contrast-enhanced computed tomography demonstrated severe peritoneal effusion, diffuse mesenteric contrast enhancement, and mild sternal lymphadenopathy without an identifiable intra-abdominal mass or visceral rupture. Given the substantial risks associated with a third laparotomy and the absence of a resectable focus, the clinical team shifted away from open surgery, electing to treat the compartmentalized infection through targeted medical stabilization and direct regional antimicrobial delivery.

To overcome the physical barriers posed by dense fibrinous matrices and suspected biofilms, clinicians implemented an adjunctive regional antimicrobial delivery protocol using an ultrasound-guided peritoneal catheter. Under sterile technique, a multi-fenestrated twelve-gauge catheter was placed in the right caudoventral abdomen to drain peritoneal effusion before drug instillation. Intraperitoneal meropenem was selected due to carbapenem stability against beta-lactamases and proven activity exceeding staphylococcal biofilm eradication thresholds in experimental models. Meropenem was reconstituted to 20 milligrams per milliliter and administered intraperitoneally at 12 milligrams per kilogram every eight hours, diluted in 20 milliliters of warmed saline carrier vehicle. Following infusion, the catheter was clamped for a one-hour dwell time, during which the dog was repositioned every thirty minutes to optimize intra-abdominal drug distribution before opening to gravity drainage. Concurrently, intravenous meropenem was administered at the identical dose, offset by one hour from intraperitoneal administration to maintain sustained systemic and tissue antimicrobial concentrations without inducing adverse effects.

Hospitalization required intensive supportive interventions to mitigate multisystemic complications while managing brittle diabetes mellitus. Intravenous balanced crystalloids provided cardiovascular volume support, supplemented by brief norepinephrine infusions at 0.1 to 0.2 micrograms per kilogram per minute to resolve transient hypotension. Multimodal analgesia was maintained using continuous infusions of methadone, lidocaine, and ketamine, while enoxaparin was administered subcutaneously at 0.5 milligrams per kilogram every twelve hours for thromboprophylaxis. Glycemic regulation demanded continuous glucose monitoring, with insulin doses titrated daily between 2 and 5 units twice daily to avert dangerous hypoglycemic episodes. Enteral nutrition was preserved via nasogastric tube feeding paired with maropitant and ondansetron. Following three days of dual-route meropenem therapy, peritoneal drain output dropped below two milliliters per kilogram daily, effusion resolved on ultrasound, and drain fluid cytology cleared of bacteria, enabling discharge on oral enrofloxacin for six weeks. However, four weeks later, the dog presented with large-volume recurrent effusion, severe neutropenia, and profound thrombocytopenia, leading the owners to elect humane euthanasia.

This case provides important clinical insights into managing refractory intra-abdominal infections while highlighting notable investigative limitations. The clinical course demonstrates that when septic peritonitis recurs without a surgically correctable luminal perforation, clinicians should suspect biofilm formation and localized immune complex deposition characteristic of bacterial pseudomycetoma. Furthermore, regional intraperitoneal carbapenem delivery achieved rapid, temporary source control comparable to open surgical debridement, suggesting utility as a salvage therapy when governed by strict antimicrobial stewardship. Nonetheless, the authors emphasized key diagnostic constraints inherent to a single case report. Advanced biofilm assays, crystal violet quantification, and bacterial molecular typing were not performed, leaving strain persistence and biofilm formation inferred from identical susceptibility patterns and histopathology rather than directly confirmed. Additionally, pharmacokinetic profiles of intraperitoneal meropenem were derived from experimental literature rather than canine peritoneal sampling, and a post-mortem examination was declined. Despite these limitations, the report underscores the critical necessity of correlating cytological, histopathological, and microbiological findings in refractory veterinary peritonitis.

Subject of Research: Canine chronic recurrent septic peritonitis caused by Staphylococcus pseudintermedius bacterial pseudomycetoma

Article Title: Chronic Recurrent Septic Peritonitis in a Diabetic Dog Caused by Staphylococcus pseudintermedius With Splendore–Hoeppli Reaction (Botryomycosis‐Like/Bacterial Pseudomycetoma)

Article References: Taylor, D., Granger, K. L., & Cohen, A. (2026). Chronic Recurrent Septic Peritonitis in a Diabetic Dog Caused by Staphylococcus pseudintermedius With Splendore–Hoeppli Reaction (Botryomycosis‐Like/Bacterial Pseudomycetoma). Veterinary Medicine and Science, 12(6), Article e71324. https://doi.org/10.1002/vms3.71324

Image Credits: AI Generated

DOI: 10.1002/vms3.71324

Keywords: Veterinary Medicine, Septic Peritonitis, Staphylococcus pseudintermedius, Splendore-Hoeppli Phenomenon, Bacterial Pseudomycetoma, Biofilm Infection, Meropenem, Canine Diabetes Mellitus, Chronic, Recurrent, Septic, Peritonitis

News Source: William Thompson. (November 9, 2026). Diabetic Dog Develops Recurrent Peritonitis Linked to Rare Bacterial Pseudomycetoma. Scienmag.

Tags: Bacterial Pseudomycetomabiofilm infectioncanine diabetes mellituschronicmeropenemperitonitisRecurrentsepticSeptic PeritonitisSplendore-Hoeppli PhenomenonStaphylococcus pseudintermediusveterinary medicine
Share12Tweet7Share2ShareShareShare1

Related Posts

Scoping Review Finds Only Four Studies on Maxillofacial Trauma in LGBTQIA+ Violence

Scoping Review Finds Only Four Studies on Maxillofacial Trauma in LGBTQIA+ Violence

November 19, 2026
German Society of Neurology Updates Guidelines for HIV-Associated Neurological Disorders

German Society of Neurology Updates Guidelines for HIV-Associated Neurological Disorders

November 19, 2026

Multitechnology Prenatal Testing Clarifies Outcomes for Fetuses With Mosaic Isodicentric Y Chromosomes

November 19, 2026

Surgical Risk Prediction Models Show Disparities and Sparse Auditing Across Patient Groups

November 19, 2026

POPULAR NEWS

  • Municipal Leaders Rely on Tech Champions Lacking Training and Compensation

    Municipal Leaders Rely on Tech Champions Lacking Training and Compensation

    29 shares
    Share 12 Tweet 7
  • Virtual Reality Cognitive Games Show Preliminary Promise for Stroke Recovery Outcomes

    29 shares
    Share 12 Tweet 7
  • Alzheimer’s Risk Gene SORL1 Deficiency Impairs Mitochondrial Function in Human Microglia

    29 shares
    Share 12 Tweet 7
  • Optimized Streptozotocin Delivery Regimen Improves Sporadic Alzheimer’s Disease Modeling in Rodents

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Repurposed Antihypertensive Syrosingopine Traps Lactate and Sensitizes Tumors to Metabolic Stress

Scoping Review Finds Only Four Studies on Maxillofacial Trauma in LGBTQIA+ Violence

German Society of Neurology Updates Guidelines for HIV-Associated Neurological Disorders

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.